Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Heinze

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Cephalalgia : an International Journal of Headache|November 8, 2021
Erenumab versus topiramate for the prevention of migraine - a randomised, double-blind, active-controlled phase 4 trialUwe Reuter, Marc Ehrlich, Astrid Gendolla, et al.
Brain Stimulation|December 4, 2014
Imaging sensory effects of occipital nerve stimulation: a new computer-based method in neuromodulationAnna Göbel, Carl H Göbel, Axel Heinze, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 8, 2007
Genetic association studies of the chromosome 15 GABA-A receptor cluster in migraine with auraChristian Netzer, Jan Freudenberg, Mohammad R Toliat, et al.
Pain and Therapy|July 27, 2021
Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort StudyCarl H Göbel, Axel Heinze, Sarah Karstedt, et al.
Human Mutation|August 20, 2005
Rare missense variants in ATP1A2 in families with clustering of common forms of migraineUnda Todt, Martin Dichgans, Karin Jurkat-Rott, et al.
Brain Communications|August 18, 2021
Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort studyCarl H Göbel, Axel Heinze, Sarah Karstedt, et al.
Therapeutics and Clinical Risk Management|March 23, 2026
Real-World Clinical Effectiveness and Migraine-Related Healthcare Resource Utilization in Patients Initiating Fremanezumab in Germany and the United KingdomAxel Heinze, Shazia K Afridi, Todor I Totev, et al.
Vaccines|February 26, 2025
Comparison of Phenotypes of Headaches After COVID-19 Vaccinations Differentiated According to the Vaccine UsedCarl Hartmut Göbel, Axel Heinze, Katja Heinze-Kuhn, et al.
European Heart Journal|February 25, 2016
Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trialHeinrich P Mattle, Stefan Evers, David Hildick-Smith, et al.
JAMA Network Open|June 17, 2025
Erenumab for Chronic Cluster Headache: A Randomized Clinical TrialJasper Mecklenburg, Charly Gaul, Mira Fitzek, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cephalalgia : an International Journal of Headache|November 8, 2021
Erenumab versus topiramate for the prevention of migraine - a randomised, double-blind, active-controlled phase 4 trialUwe Reuter, Marc Ehrlich, Astrid Gendolla, et al.
Brain Stimulation|December 4, 2014
Imaging sensory effects of occipital nerve stimulation: a new computer-based method in neuromodulationAnna Göbel, Carl H Göbel, Axel Heinze, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 8, 2007
Genetic association studies of the chromosome 15 GABA-A receptor cluster in migraine with auraChristian Netzer, Jan Freudenberg, Mohammad R Toliat, et al.
Pain and Therapy|July 27, 2021
Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort StudyCarl H Göbel, Axel Heinze, Sarah Karstedt, et al.
Human Mutation|August 20, 2005
Rare missense variants in ATP1A2 in families with clustering of common forms of migraineUnda Todt, Martin Dichgans, Karin Jurkat-Rott, et al.
Brain Communications|August 18, 2021
Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort studyCarl H Göbel, Axel Heinze, Sarah Karstedt, et al.
Therapeutics and Clinical Risk Management|March 23, 2026
Real-World Clinical Effectiveness and Migraine-Related Healthcare Resource Utilization in Patients Initiating Fremanezumab in Germany and the United KingdomAxel Heinze, Shazia K Afridi, Todor I Totev, et al.
Vaccines|February 26, 2025
Comparison of Phenotypes of Headaches After COVID-19 Vaccinations Differentiated According to the Vaccine UsedCarl Hartmut Göbel, Axel Heinze, Katja Heinze-Kuhn, et al.
European Heart Journal|February 25, 2016
Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trialHeinrich P Mattle, Stefan Evers, David Hildick-Smith, et al.
JAMA Network Open|June 17, 2025
Erenumab for Chronic Cluster Headache: A Randomized Clinical TrialJasper Mecklenburg, Charly Gaul, Mira Fitzek, et al.
Pageof 4